RBC Capital has lowered its rating on Sarepta Therapeutics (NASDAQ:SRPT) to sector perform, citing a run up in the stock ...

RBC Capital Markets upgraded Centrica on Friday to ‘outperform’ from ‘sector perform’ and lifted the price target to 170p ...

RBC Capital upgraded GoodRx (GDRX) to outperform, citing growth opportunities provided by its integrated savings program, ...

Royal Bank of Canada on Thursday reported a rise in second-quarter profit as the lender's personal and commercial banking ...

RBC Capital analyst Michael Siperco maintained a Buy rating on Centerra Gold (CGAU – Research Report) on May 29 and set a price target of ...

RBC Capital analyst Alex Barkley maintained a Buy rating on De Grey Mining Ltd (DGMLF – Research Report) on May 29 and set a price target of A$1.80. The company’s shares closed yesterday at $0.71.

Royal Bank of Canada beat analysts’ estimates on strong performance from its capital-markets business and lower-than-expected ...

In the U.S., RBC Wealth Management operates as a division of RBC Capital Markets. The firm has $583 billion in total client assets, with more than 2,100 financial advisors operating in 190 locations ...

RBC Capital upgrades GoodRX to Outperform, signaling strong market potential. GoodRx introduces discounts up to 43% on ...

Royal Bank of Canada (RBC) , the country's No.1 bank, on Thursday surpassed analysts' expectations for quarterly profit, ...

The moves came as RBC said it earned $3.95 billion or $2.74 per diluted share for the quarter ended April 30, up from $3.68 ...

RBC Capital has lowered its rating on Sarepta Therapeutics (NASDAQ:SRPT) to sector perform, citing a run up in the stock ahead of an expected FDA decision on June 21 for its drug Elevidys in the ...